In vivo tumor transfection mediated by polyplexes based on biodegradable poly(DMAEA)-phosphazene
- 1 December 2005
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 109 (1-3) , 275-287
- https://doi.org/10.1016/j.jconrel.2005.05.030
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Theoretical considerations involving the pharmacokinetics of plasmid DNAAdvanced Drug Delivery Reviews, 2005
- Current strategies in cancer gene therapyEuropean Journal of Pharmacology, 2004
- Strategies to Improve DNA Polyplexes for in Vivo Gene Transfer: Will “Artificial Viruses” Be the Answer?Pharmaceutical Research, 2004
- Polymer Side-Chain Degradation as a Tool to Control the Destabilization of PolyplexesPharmaceutical Research, 2004
- Cellular Vehicles for Cancer Gene TherapyBioDrugs, 2004
- Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical TrialsTechnology in Cancer Research & Treatment, 2003
- Targeting tumors with non-viral gene delivery systemsDrug Discovery Today, 2002
- Gene delivery with synthetic (non viral) carriersInternational Journal of Pharmaceutics, 2001
- Key issues in non-viral gene delivery1PII of original article: S0169-409X(98)00048-9. The article was originally published in Advanced Drug Delivery Reviews 34 (1998) 3–19.1Advanced Drug Delivery Reviews, 2001
- Cationic Polymer Based Gene Delivery SystemsPharmaceutical Research, 2000